Sumatriptan

Common brands: Imitrex, Tosymra, Topamax, Neurontin, Pain Relief

Top reporter: Glaxosmithkline Llc

Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]
37,360
Total Reports
9,787
Serious Reports
882
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.36%)

Patient Demographics

Male
5,087
Female
29,055

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Sumatriptan.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 5,446
13.1%
2 HEADACHE 3,127
7.5%
3 NAUSEA 2,831
6.8%
4 MIGRAINE 2,760
6.6%
5 FATIGUE 2,119
5.1%
6 PAIN 1,982
4.8%
7 DIZZINESS 1,690
4.1%
8 VOMITING 1,622
3.9%
9 DYSPNOEA 1,347
3.2%
10 OFF LABEL USE 1,266
3.0%
11 ANXIETY 1,259
3.0%
12 DIARRHOEA 1,195
2.9%
13 ARTHRALGIA 1,062
2.5%
14 MALAISE 1,058
2.5%
15 DEPRESSION 1,039
2.5%
16 INJECTION SITE PAIN 934
2.2%
17 FEELING ABNORMAL 916
2.2%
18 INSOMNIA 888
2.1%
19 DRUG HYPERSENSITIVITY 871
2.1%
20 CHEST PAIN 863
2.1%
21 FALL 803
1.9%
22 ASTHENIA 797
1.9%
23 PARAESTHESIA 789
1.9%
24 RASH 782
1.9%
25 SOMNOLENCE 734
1.8%
26 PAIN IN EXTREMITY 716
1.7%
27 PRURITUS 715
1.7%
28 PRODUCT QUALITY ISSUE 708
1.7%
29 PRODUCT DOSE OMISSION ISSUE 698
1.7%
30 CONDITION AGGRAVATED 681
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.